EA201170368A1 - ANTI-MICROBIAL COMPOSITION - Google Patents
ANTI-MICROBIAL COMPOSITIONInfo
- Publication number
- EA201170368A1 EA201170368A1 EA201170368A EA201170368A EA201170368A1 EA 201170368 A1 EA201170368 A1 EA 201170368A1 EA 201170368 A EA201170368 A EA 201170368A EA 201170368 A EA201170368 A EA 201170368A EA 201170368 A1 EA201170368 A1 EA 201170368A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- composition
- pharmaceutically acceptable
- diseases
- fluoroquinolone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к ветеринарной медицине, в частности к препаратам, предназначенным для профилактики и лечения заболеваний, вызванных грамположительными и грамотрицательными микроорганизмами, простейшими, например возбудителями сальмонеллеза, колибактериоза, пастереллеза, микоплазмоза и других заболеваний. Противомикробная композиция содержит триметоприм, и/или по меньшей мере один фторхинолон, или по меньшей мере одну фармацевтически приемлемую соль фторхинолона, по меньшей мере одну органическую кислоту, вспомогательные вещества и фармацевтически приемлемый растворитель, при этом дополнительно содержит по меньшей мере один макролидный антибиотик или по меньшей мере одну фармацевтически приемлемую соль макролидного антибиотика. Таким образом, заявляемое изобретение представляет собой противомикробную композицию, которая благодаря своему качественному и количественному составу обладает высокой терапевтической эффективностью при лечении смешанных инфекционных заболеваний. Также применение композиции по данному изобретению обеспечивает большую эффективность, простоту обработки субъектов, подвергающихся лечению, является экономически целесообразным и безопасным за счет снижения вероятности побочного эффекта компонентов композиции.The invention relates to veterinary medicine, in particular to drugs intended for the prevention and treatment of diseases caused by gram-positive and gram-negative microorganisms, protozoa, such as pathogens of salmonellosis, colibacteriosis, pasteurellosis, mycoplasmosis and other diseases. The antimicrobial composition contains trimethoprim, and / or at least one fluoroquinolone, or at least one pharmaceutically acceptable fluoroquinolone salt, at least one organic acid, excipients and a pharmaceutically acceptable solvent, and additionally contains at least one macrolide antibiotic or at least one pharmaceutically acceptable salt of a macrolide antibiotic. Thus, the claimed invention is an antimicrobial composition, which due to its qualitative and quantitative composition has a high therapeutic efficacy in the treatment of mixed infectious diseases. Also, the use of the composition according to this invention provides greater efficiency, ease of treatment of subjects undergoing treatment, is economically feasible and safe by reducing the likelihood of side effects of the components of the composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201000872A UA94177C2 (en) | 2010-01-29 | 2010-01-29 | antimicrobial composition |
PCT/IB2010/051613 WO2011092551A1 (en) | 2010-01-29 | 2010-04-14 | Antimicrobial composition |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201170368A1 true EA201170368A1 (en) | 2012-01-30 |
EA019978B1 EA019978B1 (en) | 2014-07-30 |
Family
ID=44318719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201170368A EA019978B1 (en) | 2010-01-29 | 2010-04-14 | Antimicrobial composition |
Country Status (3)
Country | Link |
---|---|
EA (1) | EA019978B1 (en) |
UA (1) | UA94177C2 (en) |
WO (1) | WO2011092551A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA108238C2 (en) * | 2012-12-24 | 2015-04-10 | ANTIBACTERIAL COMPOSITION | |
CN117598997A (en) * | 2023-08-21 | 2024-02-27 | 沈阳伟嘉生物技术有限公司 | Tilmicosin-natural plant organic acid microcrystalline double salt powder preparation and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1712220A1 (en) * | 2005-04-15 | 2006-10-18 | PARI GmbH Spezialisten für effektive Inhalation | Pharmaceutical aerosol composition |
UA46335U (en) * | 2009-10-21 | 2009-12-10 | Анатолій Альбертович Кузьмін | Antibacterial composition |
-
2010
- 2010-01-29 UA UAA201000872A patent/UA94177C2/en unknown
- 2010-04-14 EA EA201170368A patent/EA019978B1/en not_active IP Right Cessation
- 2010-04-14 WO PCT/IB2010/051613 patent/WO2011092551A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011092551A1 (en) | 2011-08-04 |
EA019978B1 (en) | 2014-07-30 |
UA94177C2 (en) | 2011-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ751197A (en) | Compounds and methods of treating infections | |
BR112015003188A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, COMPOUND USE, AND METHOD FOR TREATMENT OF A RORGAMMAT-MEDIATED DISEASE OR CONDITION IN A PATIENT | |
BR112015027699A2 (en) | USE OF ROBENIDINE OR A THERAPEUTICLY ACCEPTABLE SALT THEREOF, ANTIBACTERIAL PHARMACEUTICAL COMPOSITION AND MEDICAL DEVICE | |
MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
BR112015009168A2 (en) | compound of formula xi, use of a compound, pharmaceutical composition, method of treating a pde4-mediated disease in a subject, method of modulating a pde4-mediated function in a subject, method of achieving an effect in a patient, and method to inhibit pde4 | |
EA201390626A1 (en) | DERIVATIVES OF HYDROXAMIC ACID AND APPLICATION OF INDICATED DERIVATIVES IN THE TREATMENT OF BACTERIAL INFECTIONS | |
BR112015014458A2 (en) | mannose derivatives for the treatment of bacterial infections | |
EA201692506A2 (en) | ANTI-FLY VIRUS REPLICATION INHIBITORS | |
MX359989B (en) | Antiviral drugs for treatment of arenavirus infection. | |
EA201100613A1 (en) | CONDENSED, SPYROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
EA201170689A1 (en) | ANTI-MICROBIAL COMPOSITIONS | |
MX340985B (en) | N-heteroaryl compounds. | |
EA201590697A1 (en) | DERIVATIVES OF KETAMINE | |
NZ596628A (en) | Ketolide compounds having antimicrobial activity | |
BR112019018615A2 (en) | antimicrobial compounds, compositions and uses thereof | |
MX2015012472A (en) | Mannose derivatives for treating bacterial infections. | |
MY186959A (en) | New effective aminoglycoside antibiotic for multidrug-resistant bacteria | |
EA201170368A1 (en) | ANTI-MICROBIAL COMPOSITION | |
MX357352B (en) | Use of polyaminoisoprenyl derivatives in antibiotic or antiseptic treatment. | |
ECSP088132A (en) | INHIBITORS OF 6-ALQUILIDENO-PENEME B-LACTAMASA BICYCLES AND ANTIBIOTIC COMBINATION OF ß-LACTAMA: A SPECTRO ANTIBIOTIC | |
CL2009000470A1 (en) | Substituted 6-oxo-2,3-dihydro-6h-1-oxa-3,3a-diaza-phenalene derivative compounds; procedure for preparing the compounds; pharmaceutical composition; and its use in the treatment of bacterial infections, particularly useful against gram (+) and gram (-) bacteria, such as streptococcus, staphilococcus and escherichia coli, among others. | |
WO2014145713A3 (en) | Aminoglycoside antibiotics with reduced ototoxicity | |
EA201400830A1 (en) | ANTIBACTERIAL PHARMACEUTICAL COMPOSITION | |
EA200970881A1 (en) | ANTIBACTERIAL COMPOSITION | |
EA201590351A1 (en) | PEPTIDE COMBINATIONS WITH A CYCLIZED MAIN CHAIN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM KG MD TJ TM |